CardioRenal Medicine

Scope & Guideline

Innovating Research for a Healthier Heart and Kidney.

Introduction

Welcome to the CardioRenal Medicine information hub, where our guidelines provide a wealth of knowledge about the journal’s focus and academic contributions. This page includes an extensive look at the aims and scope of CardioRenal Medicine, highlighting trending and emerging areas of study. We also examine declining topics to offer insight into academic interest shifts. Our curated list of highly cited topics and recent publications is part of our effort to guide scholars, using these guidelines to stay ahead in their research endeavors.
LanguageEnglish
ISSN1664-3828
PublisherKARGER
Support Open AccessYes
CountrySwitzerland
TypeJournal
Converge2011, from 2013 to 2024
AbbreviationCARDIORENAL MED / CardioRenal Med.
Frequency6 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND

Aims and Scopes

The journal 'CardioRenal Medicine' focuses on the intricate relationships between cardiovascular and renal health, emphasizing the interplay between these two vital systems in various disease contexts. It aims to disseminate research that explores pathophysiological mechanisms, clinical management, and innovative therapeutic approaches to cardiorenal syndromes.
  1. Cardiorenal Interactions:
    The journal emphasizes the study of interactions between cardiovascular and renal systems, particularly in conditions like heart failure and chronic kidney disease, highlighting how dysfunction in one system can affect the other.
  2. Innovative Therapeutic Strategies:
    Research published often explores new treatment modalities and their effects on cardiorenal outcomes, including pharmacological interventions, surgical techniques, and novel devices aimed at improving patient outcomes.
  3. Diagnostic and Prognostic Biomarkers:
    A significant focus is placed on identifying and validating biomarkers that can predict renal and cardiovascular outcomes, enhancing the ability to manage patients effectively.
  4. Real-World Evidence and Clinical Studies:
    The journal publishes studies that provide real-world insights into the management of cardiorenal diseases, emphasizing practical approaches and outcomes in diverse patient populations.
  5. Emerging Technologies in Cardiorenal Medicine:
    Research on the application of advanced technologies, including artificial intelligence and point-of-care ultrasound, is a critical area of interest, aimed at improving diagnosis and treatment strategies.
Recent publications in 'CardioRenal Medicine' reveal several emerging themes and trends that highlight the journal's responsiveness to evolving scientific and clinical landscapes. These trends reflect a growing interest in multifaceted approaches to cardiorenal health.
  1. Artificial Intelligence and Machine Learning:
    The incorporation of AI and machine learning in predicting outcomes and personalizing treatment plans is gaining traction, indicating a forward-looking approach to patient management.
  2. Precision Medicine in Cardiorenal Disease:
    There is an increasing focus on tailoring treatments based on individual patient characteristics, such as genetic markers and comorbidities, which promises to enhance the efficacy of interventions.
  3. Management of Comorbidities:
    The intersection of cardiorenal disease with other conditions, such as diabetes and obesity, is becoming a prominent research area, acknowledging the complexity of managing patients with multiple health challenges.
  4. Exploration of Novel Biomarkers:
    The identification and validation of new biomarkers for early diagnosis and prognosis of cardiorenal syndromes is emerging as a critical area of research, with implications for improving patient outcomes.
  5. Integrated Care Models:
    There is a trend towards research that promotes integrated care models, which address both cardiovascular and renal health simultaneously, reflecting a holistic approach to patient management.

Declining or Waning

As the field of CardioRenal Medicine evolves, certain themes have become less prominent in recent publications. This decline may reflect shifts in research priorities, emerging technologies, or changes in clinical practice.
  1. Traditional Diuretic Therapies:
    While diuretics remain essential in managing fluid overload, the focus on traditional diuretic therapies has waned in favor of more innovative approaches and combination therapies that address complex patient needs.
  2. Basic Mechanistic Studies:
    There appears to be a decline in purely mechanistic studies that do not translate into clinical applications, as the journal shifts towards research with direct relevance to patient care and outcomes.
  3. Single-System Focus Studies:
    Research solely targeting either cardiovascular or renal systems without considering their interplay has decreased, reflecting a broader recognition of the importance of integrated approaches to patient management.

Similar Journals

HEART FAILURE REVIEWS

Shaping the Future of Heart Health Through Rigorous Review
Publisher: SPRINGERISSN: 1382-4147Frequency: 6 issues/year

HEART FAILURE REVIEWS is a premier academic journal published by Springer, dedicated to the dynamic field of cardiology and cardiovascular medicine. With an impressive Q1 ranking in 2023, the journal stands as a vital resource for researchers, clinicians, and students seeking to stay abreast of the latest developments in heart failure management and research. Covering a broad spectrum of topics, including innovative therapies, epidemiology, and pathophysiology of heart failure, it fosters an environment for interdisciplinary collaboration. The journal is indexed with an ISSN of 1382-4147 and an E-ISSN of 1573-7322, ensuring widespread dissemination of knowledge. Although it does not currently offer open access options, its rigorous peer-review process guarantees high-quality content that contributes significantly to the scientific community. Established in 1996 and running through 2024, HEART FAILURE REVIEWS continues to be a leading platform for advancing understanding and treatment of heart conditions, making it an indispensable resource for all stakeholders in cardiac health.

Frontiers in Cardiovascular Medicine

Advancing Cardiovascular Knowledge for a Healthier Tomorrow.
Publisher: FRONTIERS MEDIA SAISSN: 2297-055XFrequency: 1 issue/year

Frontiers in Cardiovascular Medicine is a leading open-access journal published by FRONTIERS MEDIA SA, dedicated to advancing research in the field of cardiology and cardiovascular medicine. Since its inception in 2014, the journal has become a vital platform for the dissemination of high-quality research, boasting a commendable Q2 rank in the 2023 category for Cardiology and Cardiovascular Medicine. With a focus on promoting innovative studies and clinical insights, Frontiers in Cardiovascular Medicine facilitates open access to its content, allowing researchers, healthcare professionals, and students from around the globe to engage with the latest findings which are critical for the advancement of cardiovascular health. The journal's significant presence in the academic landscape, as indicated by its Scopus ranking (161/387 and 58th percentile), underscores its importance as a research outlet in this essential field. Located in Lausanne, Switzerland, the journal continues to support the global cardiovascular community by encouraging collaboration and knowledge sharing to address the challenges faced in cardiovascular medicine today.

Journal of the Saudi Heart Association

Fostering Innovation in Cardiology for Global Impact
Publisher: DIGITAL COMMONS BEPRESSISSN: 1016-7315Frequency: 4 issues/year

The Journal of the Saudi Heart Association is a prominent scholarly publication dedicated to advancing knowledge in the fields of cardiology and cardiovascular medicine. Published by DIGITAL COMMONS BEPRESS, this open-access journal has been serving the global community since 2009, providing a vital platform for researchers, practitioners, and students interested in the latest developments in heart health and disease management. With an ISSN of 1016-7315 and a growing repository of knowledge alongside an E-ISSN of 2212-5043, the journal showcases an array of peer-reviewed articles that contribute to the understanding of cardiovascular conditions. Although categorized in the Q4 quartile for 2023, it remains committed to offering valuable insights, particularly within the constraints of the 29th percentile rank specified by Scopus. As the journal converges towards 2024, it continues to foster collaboration, innovation, and inquiry within the Saudi Arabian and international medical communities.

SEMINARS IN NEPHROLOGY

Connecting Research and Clinical Practice in Nephrology
Publisher: W B SAUNDERS CO-ELSEVIER INCISSN: 0270-9295Frequency: 6 issues/year

SEMINARS IN NEPHROLOGY, published by W B SAUNDERS CO-ELSEVIER INC, stands as a premier journal in the field of nephrology, with a notable impact factor in its category. With its dedicated scope spanning significant developments from 1981 to 2024, this journal provides an essential platform for researchers, clinicians, and students to explore critical advances in renal medicine. Noteworthy for its classification in the Q1 quartile of nephrology journals, SEMINARS IN NEPHROLOGY ranks #18 out of 81 in Scopus, placing it in the 78th percentile of its field, which underscores its influence and contribution to contemporary research. While it currently does not offer open access, the journal remains a vital resource for anyone seeking to deepen their understanding of nephrological advancements and complexities. With an established address located at 1600 John F. Kennedy Boulevard, Ste 1800, Philadelphia, PA 19103-2899, it continues to draw a global readership committed to the pursuit of knowledge in kidney health and disease.

Minerva Cardiology and Angiology

Transforming cardiovascular practices with cutting-edge findings.
Publisher: EDIZIONI MINERVA MEDICAISSN: 2724-5683Frequency: 6 issues/year

Minerva Cardiology and Angiology, published by EDIZIONI MINERVA MEDICA, is a prominent journal in the field of cardiology and cardiovascular medicine, with an ISSN of 2724-5683 and E-ISSN of 2724-5772. Established in 2021, this journal aims to foster the dissemination of cutting-edge research, clinical practice guidelines, and innovative methodologies relevant to cardiovascular health. As of 2023, it holds a commendable Q3 quartile rank in its category, reflecting its growing influence within the scientific community. The journal is indexed in Scopus, where it ranks #221 out of 387 in its field, placing it in the 43rd percentile overall. Although it currently does not offer Open Access options, articles published in Minerva Cardiology and Angiology contribute significantly to ongoing discussions and advancements in heart and vascular health. The journal serves as an invaluable resource for researchers, healthcare professionals, and students seeking to stay informed on the latest developments in cardiology.

Indian Heart Journal

Advancing Cardiac Knowledge for a Healthier Tomorrow
Publisher: ELSEVIERISSN: 0019-4832Frequency: 6 issues/year

Indian Heart Journal, published by Elsevier, is a distinguished peer-reviewed journal dedicated to the field of cardiology and cardiovascular medicine. Founded in 1961, this journal has been a pivotal resource for researchers, healthcare professionals, and students, providing a platform for innovative studies and insights into heart health. The journal transitioned to an Open Access model in 2013, ensuring widespread dissemination of vital research findings to enhance global understanding of cardiovascular diseases. Ranked in the Q3 category for Cardiology and Cardiovascular Medicine in 2023, it holds a reputable position in the medical community, with a Scopus rank of #222 out of 387 journals in the same field, placing it in the 42nd percentile. The Indian Heart Journal strives to foster advances in clinical practice and research while addressing the unique cardiac health challenges faced in India and beyond.

Journal of Renal Injury Prevention

Elevating the discourse on kidney health and prevention.
Publisher: NIKAN RESEARCH INSTISSN: 2345-2781Frequency: 4 issues/year

Journal of Renal Injury Prevention, published by NIKAN RESEARCH INST, is an essential resource in the fields of nephrology and urology, catering to the growing need for specialized knowledge in the prevention and management of renal injuries. Since its establishment in 2017, this journal has worked diligently to contribute to the global discourse on renal health, exploring innovative strategies and emerging therapies. With an ISSN of 2345-2781 and an E-ISSN of 2345-2781, it aims to provide high-quality research that addresses critical aspects of kidney injuries and their prevention. While currently classified in the Q4 quartile for both nephrology and urology, the journal aspires to enhance its impact by nurturing robust discussions among researchers and clinicians alike. The journal is based in Isfahan, Iran, and welcomes submissions that advance our understanding of renal pathology. Given its commitment to the advancement of medical science, the Journal of Renal Injury Prevention is poised to play a key role in shaping future research and clinical practices in the field.

Cardiology Journal

Advancing cardiovascular knowledge without barriers.
Publisher: VIA MEDICAISSN: 1897-5593Frequency: 6 issues/year

Cardiology Journal, published by VIA MEDICA, stands as a prominent resource in the field of cardiology and cardiovascular medicine, with an ISSN of 1897-5593 and an E-ISSN of 1898-018X. Recognized for its Open Access model established since 1994, this journal facilitates widespread dissemination of critical research findings, allowing practitioners and researchers globally to access valuable insights without barriers. Based in Poland, with an address at UL SWIETOKRZYSKA 73, 80-180 GDANSK, it has achieved a respectable Q2 classification in 2023 for both Cardiology and Miscellaneous Medicine categories, reflecting its influence and quality within the scholarly community. With a Scopus ranking placing it at #117 out of 387 in Cardiology, it lies within the 69th percentile, underpinning its commitment to advancing knowledge in cardiovascular health. The journal’s converged years extending from 2006 to 2024 ensure it captures ongoing developments in a rapidly evolving field. As such, the Cardiology Journal serves as an indispensable platform for researchers, professionals, and students dedicated to exploring the frontiers of cardiac science and improving patient care.

Nephrologie

Exploring the future of nephrology with every article.
Publisher: SPRINGER HEIDELBERGISSN: 2731-7463Frequency: 6 issues/year

Nephrologie, published by Springer Heidelberg, is a vital addition to the field of nephrology, providing a dedicated platform for the dissemination of cutting-edge research and clinical practices in kidney health. With its ISSN 2731-7463 and E-ISSN 2731-7471, this journal facilitates open access to a range of articles aimed at enhancing understanding and treatment of renal disorders. Located in Germany, Nephrologie is recognized for its commitment to advancing nephrological knowledge despite being currently categorized in the Q4 quartile and holding a Scopus rank of #80/81 within its field, indicating its emerging potential in the academic landscape. Operating from Tiergartenstraße 17, D-69121 Heidelberg, Germany, the journal encompasses a diverse scope that includes original research, review articles, and clinical studies, fostering a collaborative environment among researchers, healthcare professionals, and students. As it converges between 2022 and 2024, Nephrologie positions itself as a crucial resource for those committed to improving renal patient care and outcomes.

CLINICAL SCIENCE

Transforming Research into Clinical Practice
Publisher: PORTLAND PRESS LTDISSN: 0143-5221Frequency: 24 issues/year

CLINICAL SCIENCE, published by PORTLAND PRESS LTD, is a prestigious journal with an established history that dates back to 1946. Renowned for its rigorous peer-reviewed articles, the journal is dedicated to advancing knowledge in the field of medicine, particularly in the nuances of clinical science and translational research. With an impressive Q1 ranking in the **Medicine (miscellaneous)** category and a Scopus rank of #32 out of 636 in general medicine, it is firmly positioned in the top 5% percentile of its field, making it an essential resource for researchers, practitioners, and students aiming to stay at the forefront of the discipline. Although the journal operates on a traditional subscription model, its influence and accessibility ensure that critical findings and innovative methodologies reach a wide audience, fostering collaboration and progress within the global medical community. The journal seeks to publish groundbreaking studies, critical reviews, and insights that can translate into improved clinical practices, thus reinforcing its mission to enhance patient care and medical knowledge.